Soticlestat
- Generic Name
- Soticlestat
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H23N3O2
- CAS Number
- 1429505-03-2
- Unique Ingredient Identifier
- 1766MU795L
- Associated Conditions
- -
- Associated Therapies
- -
A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine
- Conditions
- Interventions
- First Posted Date
- 2024-05-21
- Last Posted Date
- 2024-05-21
- Lead Sponsor
- Takeda
- Target Recruit Count
- 45
- Registration Number
- NCT06422377
- Locations
- π©π°
Epilepsihospitalet Filadelfia, Dianalund, Zealand, Denmark
A Study of Soticlestat in Healthy Adults To Evaluate the Effect on QTc Interval
- Conditions
- Interventions
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- Takeda
- Registration Number
- NCT05309902
A Study of Soticlestat Tablets in Healthy Adults
- First Posted Date
- 2022-03-17
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Takeda
- Target Recruit Count
- 96
- Registration Number
- NCT05284760
- Locations
- πΊπΈ
Celerion, Tempe, Arizona, United States
A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome
- Conditions
- Interventions
- First Posted Date
- 2021-12-20
- Last Posted Date
- 2024-02-21
- Lead Sponsor
- Takeda
- Target Recruit Count
- 400
- Registration Number
- NCT05163314
- Locations
- πΊπΈ
Pediatric Neurology PA, Winter Park, Florida, United States
π¨π¦Hospital For Sick Children, Toronto, Ontario, Canada
πΊπΈClinical Integrative Research Center of Atlanta, Atlanta, Georgia, United States
A Study of Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver Function
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 36
- Registration Number
- NCT05098054
- Locations
- πΊπΈ
Velocity, Edgewater, Florida, United States
πΊπΈGCP, Saint Petersburg, Florida, United States
ππΊCRU Hungary Unit Pest Country Flor Ferenc Hospital, Kistarcsa, Hungary
A Study of Soticlestat and Rifampin in Healthy Adults
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Takeda
- Target Recruit Count
- 15
- Registration Number
- NCT05098041
- Locations
- π¬π§
Celerion, Belfast, United Kingdom
A Study of Soticlestat With Itraconazole and Mefenamic Acid in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2021-10-01
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Takeda
- Target Recruit Count
- 28
- Registration Number
- NCT05064449
- Locations
- πΊπΈ
Celerion, Lincoln, Nebraska, United States
A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome
- First Posted Date
- 2021-06-25
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- Takeda
- Target Recruit Count
- 144
- Registration Number
- NCT04940624
- Locations
- πΊπ¦
CNPE Clinical Hospital Psychiatry of the Executive Body of the Kyiv City Council KCSA, Kyiv, Ukraine
π―π΅Kumamoto-Ezuko Medical Center for The Severely Disabled, Kumamoto-Shi, Kumamoto, Japan
π¨π¦Alberta Childrens Hospital, Calgary, Alberta, Canada
A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome
- First Posted Date
- 2021-06-24
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Takeda
- Target Recruit Count
- 270
- Registration Number
- NCT04938427
- Locations
- πΊπΈ
St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States
πΊπΈSeattle Children's Hospital, Seattle, Washington, United States
ππΊPecsi Tudomanyegyetem, Pecs, Baranya, Hungary
Study of TAK-935 as an Adjunctive Therapy in Adult Participants With Complex Regional Pain Syndrome (CRPS)
- First Posted Date
- 2019-06-19
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Millennium Pharmaceuticals, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT03990649
- Locations
- π¬π§
Lancashire Teaching Hospitals NHS Foundation Trust, Preston, England, United Kingdom
π¬π§University Hospital Southampton NHS Foundation Trust, Southampton, England, United Kingdom
π¬π§St Pancras Clinical Research, London, England, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.